Barry J. Byrne, M.D., Ph.D.
Professor and Associate Chair of Pediatrics, Molecular Genetics & Microbiology Director, Powell Gene Therapy Center, University of Florida School of Medicine
Kevin Campbell, Ph.D.
Investigator, Howard Hughes Medical Institute Director, Senator Paul D. Wellstone MDCRC, University of Iowa, Carver College of Medicine
Jeffrey Chamberlain, Ph.D.
McCaw Endowed Chair in Muscular Dystrophy
Professor, Department of Neurology, Department of Biochemistry
Professor of Medicine, Division of Medical Genetics
University of Washington School of Medicine
Eric Hoffman, Ph.D.
Associate Dean for Research, School of Pharmacy and Pharmaceutical Sciences at Binghamton University
Director, Research Center for Genetic Medicine, George Washington School of Medicine and Health Sciences
Children’s National Medical Center, Washington DC
CEO, ReveraGen BioPharma
VP, AGADA BioSciences
Co-Founder, Board Member, TRINDS LLC
Edward Michael Kaye, M.D.
CEO, Stoke Therapeutics
Scientific Board of Advisors, Prize4Life
Douglas Macdonald, PhD
Director, Research Operations and Scientific Alliances
Kannebovina Nagaraju, Ph.D.
Founding Chair and Professor, Department of Pharmaceutical Sciences, Binghamton University
President and Co-founder, Agada Biosciences Corp
Co-founder, Member of Directors, ReveraGen Biopharma
Pier Lorenzo Puri, M.D., Ph.D.
Associate Professor, Muscle Development Regeneration Program
Sanford-Burnham Medical Research Institute, La Jolla, CA
Thomas A. Rando, M.D., Ph.D.
Chief, Neurology Service, Director, Rehabilitation Research & Development Center of Excellence, Palo Alto VA Medical Center
Deputy Director, Stanford Center on Longevity, Stanford University
Director, The Glenn Laboratories for the Biology of Aging, Stanford University School of Medicine